We seek to capture the financial returns inherent in therapeutics that treat age-related disease by targeting aging damage. A global demographic shift to a more aged population and rising costs of end-of-life healthcare make this area of urgent unmet medical need a high-value investment focus.

We look for outstanding teams working on innovative, high-quality science, with a cogent pathway to extract commercial value from a therapeutic approach.